NewAmsterdam Pharma Late Tuesday Priced ~13,857M Share Secondary Offering of Ordinary Shares @$11.50/Share
Portfolio Pulse from Charles Gross
NewAmsterdam Pharma (NASDAQ:NAMS) has priced its secondary offering of 13,857,415 ordinary shares at $11.50 per share. The offering is expected to close on June 9, 2023, and the company will not receive any proceeds from it.
June 07, 2023 | 9:19 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
NewAmsterdam Pharma's secondary offering of 13.86M shares at $11.50/share may cause short-term downward pressure on the stock.
The secondary offering of NewAmsterdam Pharma's shares may lead to an increase in the supply of shares in the market, which could put downward pressure on the stock price in the short term. Additionally, the company will not receive any proceeds from the offering, which may be perceived negatively by investors.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100